A score of less than 22 points on the Montreal cognitive assessment and less than 23 points on the Mini-Mental State Examination were used to confirm MCI and dementia respectively.
They found that 59.4 percent of the population had neither obesity nor sarcopenia, 21.2 percent had obesity, 14.6 percent had sarcopenia, and 4.7 percent of the population had sarcopenic obesity.
The participants with sarcopenic obesity had the greatest rate of MCI and dementia, followed by those with sarcopenia, obesity, and finally the control group.
When the team ran multivariate analyses to check for statistically relevant associations, they found that sarcopenic obesity was independently associated with an increased prevalence of MCI and dementia compared with the absence of sarcopenia and obesity.